论文部分内容阅读
目的观察丹红注射液联合地塞米松治疗腔隙性脑梗死老年患者的临床疗效。方法选取2012年1月-2015年10月在医院接受治疗的65~80岁老年腔隙性脑梗死患者80例,按随机方法分为观察组41例和对照组39例,观察组给予丹红注射液联合地塞米松进行治疗,对照组仅给予丹红注射液进行治疗,观察并比较2组患者的临床疗效以及治疗后血生化指标变化。结果观察组临床疗效明显优于对照组(P<0.05);观察组治疗后的各项血生化指标均明显优于对照组,差异有统计学意义(P<0.05)。结论对老年腔隙性脑梗死患者选择丹红注射液联合地塞米松治疗,可以明显提高治疗效果,改善患者的脑神经功能指标,值得在临床上予以推广。
Objective To observe the clinical effect of Danhong injection combined with dexamethasone in elderly patients with lacunar infarction. Methods A total of 80 elderly 65- to 80-year-old patients with lacunar infarction admitted to the hospital from January 2012 to October 2015 were randomly divided into observation group (41 cases) and control group (39 cases). The observation group was given Danhong Injection combined with dexamethasone for treatment, the control group was given only Danhong injection for treatment, observation and comparison of two groups of patients with clinical efficacy and blood biochemical changes after treatment. Results The clinical efficacy of the observation group was significantly better than that of the control group (P <0.05). The blood biochemical indexes in the observation group were significantly better than those in the control group (P <0.05). Conclusion Danhong injection combined with dexamethasone in elderly patients with lacunar infarction can significantly improve the therapeutic effect and improve the neurological function of the patients. It is worth to be popularized clinically.